BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38026792)

  • 21. Aberrant expression of cell cycle regulators in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma.
    Tzankov A; Zimpfer A; Went P; Maurer R; Pileri SA; Geley S; Dirnhofer S
    Mod Pathol; 2005 Jan; 18(1):90-6. PubMed ID: 15389259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.
    Comisso E; Scarola M; Rosso M; Piazza S; Marzinotto S; Ciani Y; Orsaria M; Mariuzzi L; Schneider C; Schoeftner S; Benetti R
    Oncogene; 2017 Jul; 36(30):4253-4266. PubMed ID: 28319064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sister chromatid cohesion defects are associated with chromosome instability in Hodgkin lymphoma cells.
    Sajesh BV; Lichtensztejn Z; McManus KJ
    BMC Cancer; 2013 Aug; 13():391. PubMed ID: 23962039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel Signature of CCNF-Associated E3 Ligases Collaborate and Counter Each Other in Breast Cancer.
    Chang SC; Hung CS; Zhang BX; Hsieh TH; Hsu W; Ding JL
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from Mainland China.
    Pan C; Jiao B; Xiao T; Hou L; Zhang W; Liu X; Xu J; Tang B; Shen L
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):265-268. PubMed ID: 28281833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mad2 promotes Cyclin B2 recruitment to the kinetochore for guiding accurate mitotic checkpoint.
    Liu S; Yuan X; Gui P; Liu R; Durojaye O; Hill DL; Fu C; Yao X; Dou Z; Liu X
    EMBO Rep; 2022 Jun; 23(6):e54171. PubMed ID: 35384228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitotic phosphatase activity is required for MCC maintenance during the spindle checkpoint.
    Foss KM; Robeson AC; Kornbluth S; Zhang L
    Cell Cycle; 2016; 15(2):225-33. PubMed ID: 26652909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma.
    Hu B; Jacobs R; Ghosh N
    Curr Hematol Malig Rep; 2018 Dec; 13(6):543-554. PubMed ID: 30338457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant cytoplasmic expression of cyclin B1 protein and its correlation with EBV-LMP1, P53 and P16(INK4A) in classical Hodgkin lymphoma in China.
    Zhao P; Lu Y; Liu L; Zhong M
    Pathol Oncol Res; 2011 Jun; 17(2):369-73. PubMed ID: 21174181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated expression of mitotic regulators is associated with B-cell lymphomagenesis in HOX11-transgenic mice.
    Chen E; Lim MS; Rosic-Kablar S; Liu J; Jolicoeur P; Dubé ID; Hough MR
    Oncogene; 2006 Apr; 25(18):2575-87. PubMed ID: 16407851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digital gene expression profiling and validation study highlight Cyclin F as an important regulator for sperm motility of chickens.
    Sun Y; Fu L; Xue F; Li Y; Xu H; Chen J
    Poult Sci; 2019 Oct; 98(10):5118-5126. PubMed ID: 31329967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma.
    Lin AY; Schnitter JM; Gordon LI
    Immunotargets Ther; 2022; 11():1-10. PubMed ID: 35237537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variation in the major mitotic checkpoint genes does not affect familial breast cancer risk.
    Vaclavicek A; Bermejo JL; Wappenschmidt B; Meindl A; Sutter C; Schmutzler RK; Kiechle M; Bugert P; Burwinkel B; Bartram CR; Hemminki K; Försti A
    Breast Cancer Res Treat; 2007 Dec; 106(2):205-13. PubMed ID: 17268814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pan-class I  PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53.
    Müller A; Gillissen B; Richter A; Richter A; Chumduri C; Daniel PT; Scholz CW
    Cell Death Dis; 2018 Mar; 9(3):384. PubMed ID: 29515122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.
    Matsuki E; Younes A
    Curr Treat Options Oncol; 2016 Jun; 17(6):31. PubMed ID: 27193488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MAD2 dependent mitotic checkpoint defects in tumorigenesis and tumor cell death: a double edged sword.
    Michel L; Benezra R; Diaz-Rodriguez E
    Cell Cycle; 2004 Aug; 3(8):990-2. PubMed ID: 15254432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cells.
    Yan H; Zhu S; Song C; Liu N; Kang J
    Cell Signal; 2012 Apr; 24(4):961-8. PubMed ID: 22234345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1).
    Kraus B; Pohlschmidt M; Leung AL; Germino GG; Snarey A; Schneider MC; Reeders ST; Frischauf AM
    Genomics; 1994 Nov; 24(1):27-33. PubMed ID: 7896286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual Chlorella-Based Cellulose Nanofibers and Their Quaternization Modification and Efficient Anionic Dye Adsorption.
    Zhang L; Huo X; Zhu J; Liu C; Wang L
    Materials (Basel); 2023 May; 16(10):. PubMed ID: 37241269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitotic checkpoint defects in human cancers and their implications to chemotherapy.
    Wang X; Cheung HW; Chun AC; Jin DY; Wong YC
    Front Biosci; 2008 Jan; 13():2103-14. PubMed ID: 17981695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.